Table 2. Summary of SGA analysis of envelope sequences.
Group* | Prime (Day 0) (i.m. and i.n) | Boost (Day 49) (i.m) | Boost (Day 112) (i.m. and i.n) | Virus Challenge (Day 147) (4000TCID50 i.r) |
I | VSV (NJ) | SFV-G replicon | VSVG (I) | SIVsmE660 |
SIV Gag, Env | SIV Gag, Env | SIV Gag, Env | ||
II | VSVG (NJ) | SFV-G replicon | VSVG (I) | SIVsmE660 |
SIV, Gag, Env, GM-CSF | SIV Gag, Env | SIV Gag, Env | ||
III | VSVG (NJ) | SFV-G replicon | VSVG (I) | |
Influenza HA | Influenza HA | Influenza HA | SIVsmE660 |